CAS 1808160-52-2

Formel: C24H25N7O2

InChl: InChI=1S/C24H25N7O2/c1-11-21(12(2)33-30-11)16-8-18-15(9-19(16)32-5)22-23(27-18)25-13(3)26-24(22)28-20-10-17(14-6-7-14)29-31(20)4/h8-10,14H,6-7H2,1-5H3,(H2,25,26,27,28)

InChI Key: JIYPVUCBRQNICX-UHFFFAOYSA-N

SMILES: CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)NC4=C3C(=NC(=N4)C)NC5=CC(=NN5C)C6CC6)OC

CF53

CAS: 1808160-52-2

CF53

Formel: C₂₄H₂₅N₇O₂

Reinheit: 99.5%

Molekulargewicht: 443.5

Ref: 54-BUP11994

N-(3-Cyclopropyl-1-methyl-1H-pyrazol-5-yl)-7-(3,5-dimethylisoxazol-4-yl)-6-methoxy-2-methyl-9H-pyrimido[4,5-b]indol-4-amine

CAS: 1808160-52-2

Formel: C₂₄H₂₅N₇O₂

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 443.5010

Ref: IN-DA01V3MA

CF53

CAS: 1808160-52-2

CF53 is a test sample for the detection of hepatitis B and C virus. It is a monoclonal antibody that binds to the envelope protein of the virus. CF53 can be used in research laboratories as a hybridization probe for nucleic acids. CF53 has been shown to have antiviral activity against the human immunodeficiency virus (HIV) and hepatitis B virus (HBV). The antiviral effect of CF53 may be due to its ability to inhibit viral replication by inhibiting reverse transcription, which is required for replication of HIV and HBV.

Formel: C₂₄H₂₅N₇O₂

Reinheit: Min. 95%

Molekulargewicht: 443.5 g/mol

Ref: 3D-IXC16052

CF53

CAS: 1808160-52-2

CF53: potent, selective oral BET inhibitor; Ki <1 nM, Kd 2.2 nM, IC50 2 nM for BRD4 BD1; high affinity for BRD2/3/4/BRDT; effective anti-tumor agent.

Formel: C₂₄H₂₅N₇O₂

Reinheit: 99.72%

Farbe und Form: Solid

Molekulargewicht: 443.501

Ref: TM-T10773